Connie Matsui

EVP, Corp. Strategy and Comm., Biogen.

Companies

Sutro BiopharmaBoard member Jun 26, 2019 to now¹
ARTELO BIOSCIENCES, INC.Board member Jun 21, 2019 to now²
Halozyme TherapeuticsBoard member Jul 31, 2006 to Dec 3, 2024³
BiogenEVP, Corp. Strategy and Comm. Jan 5, 2006 to Feb 14, 2007⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Halozyme Therapeutics HALO183,035 shares⁵$22.2M at $121.51Nov 29, 2024
Sutro Biopharma STRO50,000 shares⁶$564.0K at $11.28Oct 15, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 15, 2025Bought 50,000 shares at $0.80 of Sutro Biopharma⁶
Nov 29, 2024Gift 10,470 shares of Halozyme Therapeutics⁵
Apr 25, 2024Granted 6,501 shares of Halozyme Therapeutics⁷
May 5, 2023Granted 8,065 shares of Halozyme Therapeutics⁸
Nov 16, 2022Gift 9,250 shares of Halozyme Therapeutics⁹
May 5, 2022Granted 6,206 shares of Halozyme Therapeutics¹⁰
Nov 5, 2021Sold 12,548 shares at $40.77 of Halozyme Therapeutics¹¹
Nov 5, 2021Sold 19,452 shares at $40.13 of Halozyme Therapeutics¹¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSutro Biopharma, Board member
2
SEC EDGARARTELO BIOSCIENCES, INC., Board member
3
SEC EDGARHalozyme Therapeutics, Board member
4
SEC EDGARBiogen, EVP, Corp. Strategy and Comm.
5
SEC EDGARHalozyme Therapeutics shares after the filing of Nov 29, 2024
6
SEC EDGARSutro Biopharma shares after the filing of Oct 15, 2025
7
SEC EDGARForm 4 filed Apr 29, 2024
8
SEC EDGARForm 4 filed May 9, 2023
9
SEC EDGARForm 4 filed Nov 17, 2022
10
SEC EDGARForm 4 filed May 6, 2022
11
SEC EDGARForm 4 filed Nov 5, 2021